These alterations were also described in IBD patients and in addition, a mutation of the SLC22A5 gene encoding OCTN2, a sodium-dependent L-carnitine transporter critical for fatty acid oxidation, has been proposed as a risk factor for IBD [48]. Here, SLC22A5 is linked to inflammatory bowel disease.